30194544|t|Other Antidepressants.
30194544|a|This chapter addresses the following FDA-approved medications for the treatment of major depressive disorder available for use in the United States including bupropion, mirtazapine, trazodone, vortioxetine, and vilazodone. These medications do not belong to one of the previously featured classes of antidepressants discussed in the preceding chapters. Each medication featured in this chapter has a unique structure and properties that target diverse receptors in the central nervous system. These diverse targets are distinct from other classes of medications used to treat major depressive disorder. This chapter will provide an overview of each medication's indication for use, history of development, pharmacology, metabolism, dosing recommendations, onset of action, use in special populations, safety and tolerability, adverse effects, potential interactions with additional medications, and data regarding possible overdose with available treatments.Bupropion was initially developed for its combined effects on the norepinephrine and dopamine neurotransmitters. Currently, bupropion is the only antidepressant on the market in the United States with no appreciable activity on serotonin concentrations in the central nervous system. Bupropion is extensively metabolized in humans into three active metabolites including hydroxybupropion, threohydrobupropion, and erythrohydrobuproprion each with substantial antidepressant activity. The most serious side effect of bupropion is the development of seizures, so the dose must be gradually titrated to a maximum dose of 450 mg per day of the immediate-release formulation and 400 mg per day of the sustained-release formulation. Additional adverse effects include agitation, dry mouth, insomnia, headaches, migraines, nausea, vomiting, constipation, and tremor. The onset of action of bupropion is 2 weeks with full efficacy attained at 4 weeks of treatment. Bupropion produced similar depression remission rates when compared to SSRIs with a median time to relapse of 44 weeks. Bupropion has additionally been approved for smoking cessation and may have a combined role in treating nicotine cravings and depression.Mirtazapine has a unique method of action by enhancing norepinephrine and serotonin neurotransmission by blocking the alpha-2 presynaptic adrenoceptors resulting in increased release of serotonin at the nerve terminals. Mirtazapine additionally binds to the 5-HT2, 5-HT3, and H1 receptors resulting in increased sedation, which is the most common side effect. Additional side effects include increased appetite and weight gain, dizziness, and transient elevations in cholesterol levels and liver function tests. Mirtazapine is unlike any other antidepressant in that it also has a hormonal effect that reduces cortisol levels within the body. Patients on mirtazapine showed significant improvement in symptoms of major depressive disorder within the first 1-2 weeks of treatment with long-term studies at 40 weeks showing continued improvements in response rates in addition to lower relapse rates. Mirtazapine has an antagonistic effect at the central presynaptic 5-HT2 receptors and alpha-2 adrenergic inhibitory autoreceptors and heteroreceptors resulting in increased norepinephrine release with an indirect release of serotonin due to increased noradrenergic input to the raphe nucleus. Mirtazapine has an effective dose range from 15 to 45 mg once daily with a long half-life preventing dose adjustments more often than every 1-2 weeks.Trazadone is a 5-HT2A and 5-HT2C receptor antagonist and selective serotonin reuptake inhibitor. While trazodone has only been FDA approved for use in the treatment of major depressive disorder, it has been used off label for numerous conditions including insomnia, anxiety, dementia, Alzheimer's disease, substance abuse, schizophrenia, bulimia, and fibromyalgia. The most common adverse reaction is drowsiness, followed by dizziness, dry mouth, and nervousness. In the United States, trazadone is the second most commonly prescribed agent used to treat insomnia. The hypnotic action of this medication at lower doses is attributed primarily to the antagonism of the 5-HT2A receptors, H1 receptors, and alpha-1 adrenergic receptors. The most active metabolite is m-chlorophenylpiperazine produced by the CYP3A4 enzyme, which is a more profound inhibitor of serotonin reuptake as compared to the parent molecule of trazadone. The maximum outpatient dose should not exceed 400 mg per day in divided doses, but in hospitalized patients, the dose may be increased to a maximum dose of 600 mg daily in divided doses while the patient is being actively monitored for side effects. One third of inpatients and one half of outpatients had a significant therapeutic response to trazadone by the end of the first week with the remainder of patients responding in 2-4 weeks of therapy.Vortioxetine is a novel antidepressant classified by the World Health Organization as a N06AX antidepressant that was derived from studies targeting the combination of direct serotonin transporter inhibition and 5-HT1A receptor modulation leading to rapid desensitization of the somatodendritic 5-HT1A autoreceptors and activation of the postsynaptic 5-HT1A receptors. This medication is an antagonist at 5-HT3, 5-HT1D, and 5-HT7 receptors, an agonist at 5-HT1A receptors, and a partial agonist at 5-HT1B receptors. Blockade of the 5-HT3 receptor was noted to produce increased levels of serotonin, dopamine, norepinephrine, acetylcholine, and histamine in the prefrontal cortex and hippocampus, which are known to be associated with the development of depression. The most common adverse effect is nausea followed by sexual dysfunction, constipation, and vomiting. The maximum dose of vortioxetine is 20 mg daily with improvement in symptoms of depression noted at 2 weeks with a full therapeutic effect observed at 4-6 weeks.Vilazodone is a selective serotonin reuptake inhibitor and 5-HT1A receptor partial agonist. This medication works by enhancing serotonergic activity in the central nervous system through selective inhibition of serotonin reuptake with no significant effects noted on norepinephrine or dopamine uptake. Vilazodone additionally binds with high affinity to the 5-HT1A receptors as a partial agonist resulting in faster onset of action, greater efficacy, and better tolerability with reduced sexual side effects when compared to other SSRIs. The most common adverse effects were diarrhea, nausea, vomiting, and insomnia. Additional reported adverse effects included dizziness, dry mouth, fatigue, abnormal dreams, decreased libido, arthralgias, and palpitations which were self-limited with resolution in 4-5 days after starting the medication. The recommended therapeutic dose of vilazodone is 40 mg daily with improvement noted in depressive symptoms within 1 week of initiating therapy with increased remission rates noted at 6 weeks of therapy.The medications featured in this chapter do not fall within the major categories of antidepressant classes but add additional unique mechanisms for the treatment of major depressive disorder. Each medication targets different receptors in the central nervous system involved in the development of depression. Resolution of depressive symptoms and response rates of these medications are similar to SSRIs with reduced side effects that can often lead to discontinuation of therapy. Use of these unique medications allows clinicians to target specific symptoms and comorbidities often associated with depression resulting in improved symptom resolution and long-term maintenance of remission.
30194544	106	131	major depressive disorder	Disease	MESH:D003865
30194544	181	190	bupropion	Chemical	MESH:D016642
30194544	192	203	mirtazapine	Chemical	MESH:D000078785
30194544	205	214	trazodone	Chemical	MESH:D014196
30194544	216	228	vortioxetine	Chemical	MESH:D000078784
30194544	234	244	vilazodone	Chemical	MESH:D000069503
30194544	599	624	major depressive disorder	Disease	MESH:D003865
30194544	946	954	overdose	Disease	MESH:D062787
30194544	981	990	Bupropion	Chemical	MESH:D016642
30194544	1047	1061	norepinephrine	Chemical	MESH:D009638
30194544	1066	1074	dopamine	Chemical	MESH:D004298
30194544	1105	1114	bupropion	Chemical	MESH:D016642
30194544	1209	1218	serotonin	Chemical	MESH:D012701
30194544	1265	1274	Bupropion	Chemical	MESH:D016642
30194544	1305	1311	humans	Species	9606
30194544	1352	1368	hydroxybupropion	Chemical	MESH:C580748
30194544	1370	1389	threohydrobupropion	Chemical	MESH:C496216
30194544	1395	1417	erythrohydrobuproprion	Chemical	-
30194544	1497	1506	bupropion	Chemical	MESH:D016642
30194544	1529	1537	seizures	Disease	MESH:D012640
30194544	1743	1752	agitation	Disease	MESH:D011595
30194544	1754	1763	dry mouth	Disease	MESH:D014987
30194544	1765	1773	insomnia	Disease	MESH:D007319
30194544	1775	1784	headaches	Disease	MESH:D006261
30194544	1786	1795	migraines	Disease	MESH:D008881
30194544	1797	1803	nausea	Disease	MESH:D009325
30194544	1805	1813	vomiting	Disease	MESH:D014839
30194544	1815	1827	constipation	Disease	MESH:D003248
30194544	1833	1839	tremor	Disease	MESH:D014202
30194544	1864	1873	bupropion	Chemical	MESH:D016642
30194544	1938	1947	Bupropion	Chemical	MESH:D016642
30194544	1965	1975	depression	Disease	MESH:D003866
30194544	2058	2067	Bupropion	Chemical	MESH:D016642
30194544	2162	2170	nicotine	Chemical	MESH:D009538
30194544	2184	2194	depression	Disease	MESH:D003866
30194544	2195	2206	Mirtazapine	Chemical	MESH:D000078785
30194544	2250	2264	norepinephrine	Chemical	MESH:D009638
30194544	2269	2278	serotonin	Chemical	MESH:D012701
30194544	2381	2390	serotonin	Chemical	MESH:D012701
30194544	2415	2426	Mirtazapine	Chemical	MESH:D000078785
30194544	2460	2465	5-HT3	Gene	3359
30194544	2587	2621	increased appetite and weight gain	Disease	MESH:D015430
30194544	2623	2632	dizziness	Disease	MESH:D004244
30194544	2662	2673	cholesterol	Chemical	MESH:D002784
30194544	2707	2718	Mirtazapine	Chemical	MESH:D000078785
30194544	2805	2813	cortisol	Chemical	MESH:D006854
30194544	2838	2846	Patients	Species	9606
30194544	2850	2861	mirtazapine	Chemical	MESH:D000078785
30194544	2908	2933	major depressive disorder	Disease	MESH:D003865
30194544	3094	3105	Mirtazapine	Chemical	MESH:D000078785
30194544	3267	3281	norepinephrine	Chemical	MESH:D009638
30194544	3318	3327	serotonin	Chemical	MESH:D012701
30194544	3387	3398	Mirtazapine	Chemical	MESH:D000078785
30194544	3537	3546	Trazadone	Chemical	-
30194544	3552	3558	5-HT2A	Gene	3356
30194544	3563	3578	5-HT2C receptor	Gene	3358
30194544	3640	3649	trazodone	Chemical	MESH:D014196
30194544	3705	3730	major depressive disorder	Disease	MESH:D003865
30194544	3793	3801	insomnia	Disease	MESH:D007319
30194544	3803	3810	anxiety	Disease	MESH:D001007
30194544	3812	3820	dementia	Disease	MESH:D003704
30194544	3822	3841	Alzheimer's disease	Disease	MESH:D000544
30194544	3843	3858	substance abuse	Disease	MESH:D019966
30194544	3860	3873	schizophrenia	Disease	MESH:D012559
30194544	3875	3882	bulimia	Disease	MESH:D002032
30194544	3888	3900	fibromyalgia	Disease	MESH:D005356
30194544	3938	3948	drowsiness	Disease	
30194544	3962	3971	dizziness	Disease	MESH:D004244
30194544	3973	3982	dry mouth	Disease	MESH:D014987
30194544	3988	3999	nervousness	Disease	
30194544	4023	4032	trazadone	Chemical	-
30194544	4092	4100	insomnia	Disease	MESH:D007319
30194544	4301	4325	m-chlorophenylpiperazine	Chemical	MESH:C015068
30194544	4342	4348	CYP3A4	Gene	1576
30194544	4395	4404	serotonin	Chemical	MESH:D012701
30194544	4452	4461	trazadone	Chemical	-
30194544	4475	4485	outpatient	Species	9606
30194544	4562	4570	patients	Species	9606
30194544	4659	4666	patient	Species	9606
30194544	4726	4736	inpatients	Species	9606
30194544	4753	4764	outpatients	Species	9606
30194544	4807	4816	trazadone	Chemical	-
30194544	4868	4876	patients	Species	9606
30194544	4912	4924	Vortioxetine	Chemical	MESH:D000078784
30194544	5000	5020	N06AX antidepressant	Chemical	-
30194544	5087	5108	serotonin transporter	Gene	6532
30194544	5124	5139	5-HT1A receptor	Gene	3350
30194544	5207	5213	5-HT1A	Gene	3350
30194544	5317	5322	5-HT3	Gene	3359
30194544	5324	5330	5-HT1D	Gene	3352
30194544	5500	5509	serotonin	Chemical	MESH:D012701
30194544	5511	5519	dopamine	Chemical	MESH:D004298
30194544	5521	5535	norepinephrine	Chemical	MESH:D009638
30194544	5537	5550	acetylcholine	Chemical	MESH:D000109
30194544	5556	5565	histamine	Chemical	MESH:D006632
30194544	5665	5675	depression	Disease	MESH:D003866
30194544	5711	5717	nausea	Disease	MESH:D009325
30194544	5730	5748	sexual dysfunction	Disease	MESH:D012735
30194544	5750	5762	constipation	Disease	MESH:D003248
30194544	5768	5776	vomiting	Disease	MESH:D014839
30194544	5798	5810	vortioxetine	Chemical	MESH:D000078784
30194544	5858	5868	depression	Disease	MESH:D003866
30194544	5939	5949	Vilazodone	Chemical	MESH:D000069503
30194544	5998	6013	5-HT1A receptor	Gene	3350
30194544	6066	6078	serotonergic	Chemical	-
30194544	6150	6159	serotonin	Chemical	MESH:D012701
30194544	6206	6220	norepinephrine	Chemical	MESH:D009638
30194544	6224	6232	dopamine	Chemical	MESH:D004298
30194544	6241	6251	Vilazodone	Chemical	MESH:D000069503
30194544	6427	6446	sexual side effects	Disease	MESH:D064420
30194544	6514	6522	diarrhea	Disease	MESH:D003967
30194544	6524	6530	nausea	Disease	MESH:D009325
30194544	6532	6540	vomiting	Disease	MESH:D014839
30194544	6546	6554	insomnia	Disease	MESH:D007319
30194544	6601	6610	dizziness	Disease	MESH:D004244
30194544	6612	6621	dry mouth	Disease	MESH:D014987
30194544	6623	6630	fatigue	Disease	MESH:D005221
30194544	6632	6647	abnormal dreams	Disease	MESH:D000014
30194544	6649	6665	decreased libido	Disease	MESH:D009123
30194544	6667	6678	arthralgias	Disease	MESH:D018771
30194544	6684	6696	palpitations	Disease	MESH:D006331
30194544	6816	6826	vilazodone	Chemical	MESH:D000069503
30194544	6868	6887	depressive symptoms	Disease	MESH:D003866
30194544	7148	7173	major depressive disorder	Disease	MESH:D003865
30194544	7280	7290	depression	Disease	MESH:D003866
30194544	7306	7325	depressive symptoms	Disease	MESH:D003866
30194544	7582	7592	depression	Disease	MESH:D003866
30194544	Positive_Correlation	MESH:D016642	MESH:D004244
30194544	Association	MESH:D019966	3358
30194544	Association	MESH:D006632	MESH:D005356
30194544	Association	MESH:C015068	MESH:D006632
30194544	Association	3350	6532
30194544	Association	MESH:D006854	3352
30194544	Association	MESH:D006854	MESH:D000014
30194544	Association	MESH:C015068	MESH:D005356
30194544	Association	MESH:C015068	MESH:D005221
30194544	Association	MESH:D006632	6532
30194544	Association	MESH:D012735	3358
30194544	Association	MESH:D001007	3358
30194544	Positive_Correlation	MESH:D000078785	MESH:D009638
30194544	Association	MESH:D012559	3350
30194544	Association	MESH:D001007	6532
30194544	Association	MESH:D003704	6532
30194544	Association	MESH:D005356	3352
30194544	Association	MESH:D006854	MESH:D003967
30194544	Association	MESH:D012559	3358
30194544	Association	MESH:D006331	3358
30194544	Association	3352	3356
30194544	Association	3350	3352
30194544	Association	3350	3358
30194544	Association	MESH:D006331	6532
30194544	Association	MESH:D000109	MESH:D009123
30194544	Association	MESH:D006632	MESH:D000014
30194544	Association	MESH:D002032	3358
30194544	Association	MESH:D000014	6532
30194544	Association	MESH:D006854	MESH:D005356
30194544	Association	MESH:D016642	MESH:D000544
30194544	Association	MESH:D000109	MESH:D064420
30194544	Association	MESH:D006632	MESH:D003704
30194544	Association	MESH:D006854	3350
30194544	Association	MESH:C015068	MESH:D003704
30194544	Association	MESH:D000109	MESH:D003704
30194544	Association	MESH:D009123	1576
30194544	Association	MESH:D006632	1576
30194544	Association	MESH:D006632	3350
30194544	Association	MESH:C015068	MESH:D000014
30194544	Association	MESH:D005221	1576
30194544	Association	MESH:D002032	6532
30194544	Association	MESH:D006331	1576
30194544	Association	MESH:C015068	MESH:D018771
30194544	Association	MESH:D000109	1576
30194544	Association	MESH:C015068	MESH:D000109
30194544	Negative_Correlation	MESH:D000078784	MESH:D003865
30194544	Association	MESH:D019966	6532
30194544	Association	MESH:D018771	1576
30194544	Association	1576	3358
30194544	Association	MESH:D006854	MESH:D009123
30194544	Association	MESH:D000109	MESH:D003967
30194544	Association	MESH:D019966	3352
30194544	Association	MESH:D006854	MESH:D064420
30194544	Association	MESH:D006632	MESH:D009123
30194544	Association	MESH:D005356	6532
30194544	Association	MESH:D004298	MESH:D016642
30194544	Positive_Correlation	MESH:C580748	MESH:D016642
30194544	Association	MESH:C015068	MESH:D006331
30194544	Positive_Correlation	MESH:D016642	MESH:D009325
30194544	Association	MESH:D009123	3356
30194544	Association	MESH:D012559	3352
30194544	Association	MESH:D000109	MESH:D006331
30194544	Association	MESH:D005356	1576
30194544	Association	MESH:D001007	1576
30194544	Association	MESH:D003967	6532
30194544	Positive_Correlation	MESH:D016642	MESH:D006261
30194544	Negative_Correlation	MESH:D000078785	MESH:D003865
30194544	Positive_Correlation	MESH:D016642	MESH:D012640
30194544	Association	MESH:D064420	1576
30194544	Association	MESH:D012735	3352
30194544	Negative_Correlation	MESH:D016642	MESH:D003865
30194544	Association	MESH:D006854	1576
30194544	Association	MESH:D003704	3352
30194544	Association	MESH:D006854	MESH:D003704
30194544	Association	MESH:D003704	3350
30194544	Association	MESH:D000014	3356
30194544	Association	MESH:D002032	1576
30194544	Association	MESH:D006854	MESH:D006331
30194544	Association	MESH:D000109	3356
30194544	Association	MESH:D018771	3356
30194544	Negative_Correlation	MESH:D000069503	MESH:D003865
30194544	Association	1576	3356
30194544	Association	MESH:C015068	MESH:D003967
30194544	Association	MESH:D012735	3356
30194544	Association	MESH:D002032	3352
30194544	Negative_Correlation	MESH:D016642	MESH:D012735
30194544	Association	MESH:D005221	3356
30194544	Association	MESH:C015068	3356
30194544	Association	MESH:D003967	1576
30194544	Association	MESH:D012559	3356
30194544	Association	MESH:D000544	1576
30194544	Association	MESH:D000109	MESH:D006632
30194544	Association	MESH:C015068	3350
30194544	Positive_Correlation	MESH:D016642	MESH:D003248
30194544	Association	MESH:D000109	MESH:D006854
30194544	Association	MESH:D005221	3350
30194544	Association	MESH:D006331	3350
30194544	Association	MESH:D000109	MESH:D005221
30194544	Association	MESH:D012735	6532
30194544	Association	MESH:D006632	MESH:D006331
30194544	Association	MESH:D064420	6532
30194544	Association	MESH:D000544	3356
30194544	Association	3352	6532
30194544	Association	MESH:D000014	3350
30194544	Association	MESH:D005356	3356
30194544	Association	MESH:C015068	MESH:D009123
30194544	Positive_Correlation	MESH:D000078785	MESH:D012735
30194544	Association	MESH:D006632	MESH:D012735
30194544	Association	MESH:C015068	MESH:D012735
30194544	Association	MESH:D016642	MESH:D018771
30194544	Association	MESH:D006854	3356
30194544	Association	MESH:D005356	3350
30194544	Association	MESH:D001007	3350
30194544	Association	MESH:D006632	MESH:D006854
30194544	Association	MESH:D012735	1576
30194544	Association	MESH:D003704	1576
30194544	Association	MESH:D000014	1576
30194544	Association	MESH:D006854	MESH:D005221
30194544	Association	MESH:D064420	3350
30194544	Association	MESH:D009123	6532
30194544	Association	MESH:D002032	3350
30194544	Positive_Correlation	MESH:D016642	MESH:D006331
30194544	Association	MESH:C015068	MESH:D000544
30194544	Association	MESH:D000109	MESH:D000544
30194544	Association	MESH:C015068	MESH:D019966
30194544	Association	MESH:D003967	3350
30194544	Association	MESH:D000109	MESH:D019966
30194544	Association	MESH:D006632	3356
30194544	Association	MESH:D019966	3350
30194544	Positive_Correlation	MESH:D000078785	MESH:D012701
30194544	Association	MESH:D003704	3356
30194544	Association	MESH:D009123	3358
30194544	Association	MESH:C015068	3352
30194544	Association	1576	3352
30194544	Association	MESH:D006632	3358
30194544	Association	MESH:D016642	3359
30194544	Association	MESH:D006854	MESH:D012559
30194544	Association	MESH:D000014	3358
30194544	Association	MESH:D000109	3358
30194544	Association	MESH:D000078785	3359
30194544	Association	MESH:D064420	3358
30194544	Association	3352	3358
30194544	Association	MESH:D006854	6532
30194544	Association	MESH:D001007	3356
30194544	Positive_Correlation	MESH:D016642	MESH:D014202
30194544	Association	MESH:D006854	MESH:D000544
30194544	Association	MESH:D006854	MESH:D019966
30194544	Association	MESH:D006331	3356
30194544	Association	MESH:D009123	3352
30194544	Association	MESH:D005221	3358
30194544	Association	MESH:D012735	3350
30194544	Association	1576	6532
30194544	Association	MESH:D016642	MESH:D002032
30194544	Association	MESH:D002032	3356
30194544	Association	MESH:D005221	6532
30194544	Association	MESH:D000109	6532
30194544	Association	MESH:D006854	MESH:D002032
30194544	Association	3356	3358
30194544	Association	MESH:D000109	MESH:D001007
30194544	Association	MESH:D018771	6532
30194544	Association	MESH:D006632	MESH:D005221
30194544	Association	3358	6532
30194544	Negative_Correlation	MESH:D009538	MESH:D016642
30194544	Association	MESH:D006632	MESH:D002032
30194544	Association	MESH:D003967	3352
30194544	Association	MESH:D019966	1576
30194544	Association	MESH:C015068	3358
30194544	Association	MESH:D000544	3358
30194544	Association	MESH:D000109	MESH:D018771
30194544	Association	MESH:D000544	3352
30194544	Association	MESH:D000109	MESH:D012559
30194544	Association	MESH:C015068	6532
30194544	Positive_Correlation	MESH:D000078785	MESH:D004244
30194544	Association	MESH:D006632	MESH:D064420
30194544	Association	MESH:D012559	6532
30194544	Association	MESH:D005356	3358
30194544	Association	MESH:D006632	MESH:D000544
30194544	Association	MESH:C015068	MESH:D064420
30194544	Positive_Correlation	MESH:D016642	MESH:D014839
30194544	Association	1576	3350
30194544	Association	3356	6532
30194544	Negative_Correlation	MESH:D014196	MESH:D003865
30194544	Association	MESH:D012559	1576
30194544	Association	MESH:D000109	MESH:D012735
30194544	Association	MESH:D006854	3358
30194544	Association	MESH:D006632	MESH:D012559
30194544	Association	MESH:C015068	MESH:D012559
30194544	Association	MESH:D006854	MESH:D001007
30194544	Association	MESH:C015068	1576
30194544	Association	MESH:D001007	3352
30194544	Association	MESH:D003967	3356
30194544	Association	MESH:D006632	MESH:D001007
30194544	Positive_Correlation	MESH:C496216	MESH:D016642
30194544	Association	MESH:D003967	3358
30194544	Association	MESH:D006854	MESH:D018771
30194544	Negative_Correlation	MESH:D016642	MESH:D005221
30194544	Association	MESH:C015068	MESH:D001007
30194544	Association	MESH:D000109	3352
30194544	Association	MESH:D064420	3352
30194544	Association	3350	3356
30194544	Association	MESH:D000544	6532
30194544	Association	MESH:D000014	3352
30194544	Association	MESH:D006854	MESH:D012735
30194544	Association	MESH:D006632	MESH:D018771
30194544	Association	MESH:D006632	MESH:D003967
30194544	Association	MESH:D009123	3350
30194544	Negative_Correlation	MESH:D016642	MESH:D003866
30194544	Association	MESH:C015068	MESH:D006854
30194544	Association	MESH:D005221	3352
30194544	Association	MESH:D006632	3352
30194544	Association	MESH:D000109	MESH:D005356
30194544	Association	MESH:D000544	3350
30194544	Association	MESH:D064420	3356
30194544	Association	MESH:D003704	3358
30194544	Association	MESH:D019966	3356
30194544	Association	MESH:D000109	MESH:D000014
30194544	Association	MESH:D018771	3358
30194544	Association	MESH:D018771	3352
30194544	Association	MESH:D000109	3350
30194544	Association	MESH:D006331	3352
30194544	Association	MESH:D018771	3350
30194544	Association	MESH:C015068	MESH:D002032
30194544	Association	MESH:D000109	MESH:D002032

